Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $269,645 | 177 | 78.4% |
| Travel and Lodging | $43,265 | 104 | 12.6% |
| Food and Beverage | $14,973 | 190 | 4.4% |
| Consulting Fee | $12,644 | 6 | 3.7% |
| Honoraria | $3,300 | 3 | 1.0% |
| Education | $14.77 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $166,715 | 187 | $0 (2024) |
| Novo Nordisk Inc | $110,096 | 121 | $0 (2024) |
| Lilly USA, LLC | $38,423 | 66 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $9,291 | 9 | $0 (2019) |
| Ascendis Pharma Inc | $6,202 | 7 | $0 (2023) |
| Corcept Therapeutics | $4,010 | 7 | $0 (2019) |
| Horizon Therapeutics plc | $2,938 | 4 | $0 (2023) |
| Medtronic MiniMed, Inc. | $1,428 | 25 | $0 (2018) |
| AbbVie, Inc. | $1,365 | 2 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $725.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,833 | 47 | Amgen Inc. ($31,928) |
| 2023 | $31,136 | 43 | Amgen Inc. ($14,134) |
| 2022 | $24,391 | 26 | Novo Nordisk Inc ($24,124) |
| 2021 | $30,891 | 43 | Amgen Inc. ($20,064) |
| 2020 | $30,075 | 35 | Amgen Inc. ($22,354) |
| 2019 | $91,023 | 115 | Amgen Inc. ($61,699) |
| 2018 | $44,428 | 82 | Novo Nordisk Inc ($21,508) |
| 2017 | $54,065 | 92 | Lilly USA, LLC ($32,011) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $1,130.50 | General |
| Category: Bone Health | ||||||
| 12/15/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 12/15/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Bone Health | ||||||
| 12/07/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $763.09 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $102.72 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $919.80 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $101.74 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $847.50 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $783.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $105.81 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,667.50 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $846.96 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 10/23/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $140.25 | General |
| Category: Bone Health | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $1,191.75 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 11,945 | 153,364 | $3.6M | $1.4M |
| 2022 | 51 | 11,196 | 158,693 | $3.2M | $1.2M |
| 2021 | 50 | 11,602 | 141,414 | $2.8M | $1.1M |
| 2020 | 45 | 10,542 | 117,615 | $2.3M | $829,929 |
All Medicare Procedures & Services
197 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 68 | 66,570 | $1.3M | $528,362 | 41.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 214 | 21,120 | $887,040 | $389,113 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,619 | 2,614 | $569,852 | $235,640 | 41.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 262 | 666 | $105,228 | $36,622 | 34.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 895 | 895 | $179,895 | $32,515 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 235 | 235 | $78,490 | $27,611 | 35.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 342 | 888 | $79,032 | $23,195 | 29.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 73 | 397 | $34,142 | $19,039 | 55.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 867 | 1,147 | $55,056 | $18,869 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,381 | 2,141 | $29,974 | $17,969 | 59.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 535 | 597 | $48,357 | $17,297 | 35.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 111 | 117 | $30,537 | $11,703 | 38.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 651 | 1,190 | $33,320 | $11,313 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 166 | $24,900 | $10,538 | 42.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 866 | 1,147 | $28,675 | $10,134 | 35.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 198 | 216 | $24,408 | $8,707 | 35.7% |
| 82565 | Blood creatinine level | Office | 2023 | 491 | 909 | $13,635 | $4,559 | 33.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 109 | $7,521 | $3,955 | 52.6% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 471 | 886 | $10,632 | $3,408 | 32.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 468 | 602 | $8,428 | $3,394 | 40.3% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 49 | 71 | $8,804 | $3,377 | 38.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 468 | 602 | $8,428 | $3,045 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $7,056 | $2,986 | 42.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 287 | $14,637 | $2,931 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,578 | $2,851 | 37.6% |
About Dr. Jesus Perez, MD
Dr. Jesus Perez, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639142961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesus Perez, MD has received a total of $343,841 in payments from pharmaceutical and medical device companies, with $37,833 received in 2024. These payments were reported across 483 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($269,645).
As a Medicare-enrolled provider, Perez has provided services to 45,285 Medicare beneficiaries, totaling 571,086 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 197 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Sarasota, FL
- Active Since 02/08/2006
- Last Updated 10/18/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1639142961
Products in Payments
- EVENITY (Biological) $104,262
- Prolia (Biological) $62,419
- Ozempic (Drug) $37,340
- Tresiba (Drug) $23,533
- BASAGLAR (Drug) $17,222
- FORTEO (Drug) $15,020
- Rybelsus (Drug) $13,116
- STEGLATRO (Drug) $9,291
- Victoza (Drug) $8,777
- RYBELSUS (Drug) $4,393
- Korlym (Drug) $4,010
- Xultophy 100/3.6 (Drug) $3,673
- TEPEZZA (Drug) $2,938
- JARDIANCE (Drug) $2,194
- Androgel (Drug) $1,365
- Minimed 670G System (Device) $1,319
- STRENSIQ (Biological) $725.00
- JATENZO (Drug) $500.00
- Tymlos (Biological) $298.86
- Xultophy (Drug) $220.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Sarasota
Dr. Mark Lupo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $429,711
Dr. Raymond De La Rosa, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $123,034
Sonia Sharma, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,106
Motaz Agabani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,776
Angela Boldo, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4,101
Dr. Jose Antunes, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,974